MicroRNAs Classify Different Disease Behavior Phenotypes of Crohn's Disease and May Have Prognostic Utility

Background:There is a dire need for reliable prognostic markers that can guide effective therapeutic intervention in Crohn's disease (CD). We examined whether different phenotypes in CD can be classified based on colonic microRNA (miRNA) expression and whether miRNAs have prognostic utility for CD. Methods:High-throughput sequencing of small and total RNA isolated from colon tissue from patients with CD and controls without Inflammatory Bowel Disease (non-IBD) was performed. To identify miRNAs associated with specific phenotypes of CD, patients were stratified according to disease behavior (nonstricturing, nonpenetrating; stricturing; penetrating), and miRNA profiles in each subset were compared with those of the non-IBD group. Validation assays were performed using quantitative reverse transcription polymerase chain reaction. These miRNAs were further evaluated by quantitative reverse transcriptase polymerase chain reaction on formalin-fixed, paraffin-embedded tissue (index biopsies) of patients with nonpenetrating CD at the time of diagnosis that either retained the nonpenetrating phenotype or progressed to penetrating/fistulizing CD. Results:We found a suite of miRNAs, including miR-31-5p, miR-215, miR-223-3p, miR-196b-5p, and miR-203 that stratify patients with CD according to disease behavior independent of the effect of inflammation. Furthermore, we also demonstrated that expression levels of miR-215 in index biopsies of patients with CD might predict the likelihood of progression to penetrating/fistulizing CD. Finally, using a novel statistical simulation approach applied to colonic RNA-sequencing data for patients with CD and non-IBD controls, we identified miR-31-5p and miR-203 as candidate master regulators of gene expression profiles associated with CD. Conclusions:miRNAs may serve as clinically useful prognostic markers guiding initial therapy and identifying patients who would benefit most from effective intervention.

[1]  I. Nalbantoglu,et al.  Differential expression of miR-31 between inflammatory bowel disease and microscopic colitis. , 2015, MicroRNA.

[2]  Vikash Singh,et al.  NOD2-Nitric Oxide-responsive MicroRNA-146a Activates Sonic Hedgehog Signaling to Orchestrate Inflammatory Responses in Murine Model of Inflammatory Bowel Disease* , 2013, The Journal of Biological Chemistry.

[3]  Antonio López-Vázquez,et al.  High serum tumor necrosis factor-α levels are associated with lack of response to infliximab in fistulizing Crohn's disease , 2002, American Journal of Gastroenterology.

[4]  R. Bak,et al.  Regulation of pro-inflammatory cytokines TNFα and IL24 by microRNA-203 in primary keratinocytes. , 2012, Cytokine.

[5]  Serban Nacu,et al.  Fast and SNP-tolerant detection of complex variants and splicing in short reads , 2010, Bioinform..

[6]  Thomas Manke,et al.  MicroRNAs Differentially Expressed in Postnatal Aortic Development Downregulate Elastin via 3′ UTR and Coding-Sequence Binding Sites , 2011, PloS one.

[7]  W. Huber,et al.  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .

[8]  A. Utani,et al.  miR-196a downregulation increases the expression of type I and III collagens in keloid fibroblasts. , 2012, The Journal of investigative dermatology.

[9]  E. Ogier-Denis,et al.  Identification of Restricted Subsets of Mature microRNA Abnormally Expressed in Inactive Colonic Mucosa of Patients with Inflammatory Bowel Disease , 2010, PloS one.

[10]  S. Meltzer,et al.  MicroRNA-224 Negatively Regulates p21 Expression During Late Neoplastic Progression in Inflammatory Bowel Disease , 2013, Inflammatory bowel diseases.

[11]  David L. A. Wood,et al.  MicroRNAs and their isomiRs function cooperatively to target common biological pathways , 2011, Genome Biology.

[12]  N. Rajewsky,et al.  MiR-150 Controls B Cell Differentiation by Targeting the Transcription Factor c-Myb , 2007, Cell.

[13]  G. Corazza,et al.  Innate and adaptive immunity in inflammatory bowel disease. , 2014, Autoimmunity reviews.

[14]  C. Langford,et al.  5′ isomiR variation is of functional and evolutionary importance , 2014, Nucleic acids research.

[15]  T. Dassopoulos,et al.  Dynamic changes in the expression of MicroRNA‐31 during inflammatory bowel disease‐associated neoplastic transformation , 2010, Inflammatory bowel diseases.

[16]  S. Brant,et al.  Identification of microRNAs associated with ileal and colonic Crohn's disease† , 2010, Inflammatory bowel diseases.

[17]  A. Chinnaiyan,et al.  MicroRNA expression patterns in indeterminate inflammatory bowel disease , 2013, Modern Pathology.

[18]  P. Sethupathy,et al.  MicroRNA-29 Fine-tunes the Expression of Key FOXA2-Activated Lipid Metabolism Genes and Is Dysregulated in Animal Models of Insulin Resistance and Diabetes , 2014, Diabetes.

[19]  M. Bissonnette,et al.  miR‐143 and miR‐145 are downregulated in ulcerative colitis: Putative regulators of inflammation and protooncogenes , 2012, Inflammatory bowel diseases.

[20]  Ana Kozomara,et al.  Reducing ligation bias of small RNAs in libraries for next generation sequencing , 2012, Silence.

[21]  Z. Zhai,et al.  NOD2 Expression is Regulated by microRNAs in Colonic Epithelial HCT116 Cells , 2014, Inflammatory bowel diseases.

[22]  I. Oglesby,et al.  Regulation of Cystic Fibrosis Transmembrane Conductance Regulator by MicroRNA-145, -223, and -494 Is Altered in ΔF508 Cystic Fibrosis Airway Epithelium , 2013, The Journal of Immunology.

[23]  P. Sethupathy,et al.  Beta Cell 5′-Shifted isomiRs Are Candidate Regulatory Hubs in Type 2 Diabetes , 2013, PloS one.

[24]  A. Pivarcsi,et al.  MicroRNA-31 Is Overexpressed in Psoriasis and Modulates Inflammatory Cytokine and Chemokine Production in Keratinocytes via Targeting Serine/Threonine Kinase 40 , 2013, The Journal of Immunology.

[25]  L. Dai,et al.  Bioinformatic prediction of SNPs within miRNA binding sites of inflammatory genes associated with gastric cancer. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[26]  Noah C. Welker,et al.  Novel specific microRNA biomarkers in idiopathic inflammatory bowel disease unrelated to disease activity , 2014, Modern Pathology.

[27]  Z. Halpern,et al.  MicroRNA-132 Modulates Cholinergic Signaling and Inflammation in Human Inflammatory Bowel Disease , 2013, Inflammatory bowel diseases.

[28]  S. Brant,et al.  MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. , 2008, Gastroenterology.

[29]  Y. Liu,et al.  miR-122 targets NOD2 to decrease intestinal epithelial cell injury in Crohn's disease. , 2013, Biochemical and biophysical research communications.

[30]  D. Jewell,et al.  The intracellular sensor NOD2 induces microRNA-29 expression in human dendritic cells to limit IL-23 release. , 2013, Immunity.

[31]  R. Kolde,et al.  MicroRNA Expression Profiles of Human Blood Monocyte-derived Dendritic Cells and Macrophages Reveal miR-511 as Putative Positive Regulator of Toll-like Receptor 4* , 2011, The Journal of Biological Chemistry.

[32]  Yu Zhou,et al.  Up-Regulation of microRNA-126 May Contribute to Pathogenesis of Ulcerative Colitis via Regulating NF-kappaB Inhibitor IκBα , 2012, PloS one.

[33]  Wei Wang,et al.  MaCH‐Admix: Genotype Imputation for Admixed Populations , 2013, Genetic epidemiology.

[34]  Y. Naito,et al.  Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis , 2010, Journal of gastroenterology and hepatology.

[35]  Jay D Humphrey,et al.  Inhibition of MicroRNA-29 Enhances Elastin Levels in Cells Haploinsufficient for Elastin and in Bioengineered Vessels—Brief Report , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[36]  Jie-shou Li,et al.  Altered microRNA expression in inflamed and non‐inflamed terminal ileal mucosa of adult patients with active Crohn's disease , 2015, Journal of gastroenterology and hepatology.

[37]  S. Dalal,et al.  The Role of MicroRNA in Inflammatory Bowel Disease. , 2010, Gastroenterology & hepatology.

[38]  R. Sachidanandam,et al.  Identification and remediation of biases in the activity of RNA ligases in small-RNA deep sequencing , 2011, Nucleic acids research.

[39]  M. Rugge,et al.  PDCD4/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis , 2012, Virchows Archiv.

[40]  Xiao-ming Meng,et al.  miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. , 2010, Journal of the American Society of Nephrology : JASN.

[41]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[42]  Junfeng Zhang,et al.  miR-141 Regulates colonic leukocytic trafficking by targeting CXCL12β during murine colitis and human Crohn's disease , 2013, Gut.